Total
0
Shares
AgraFlora Organics (CSE:AGRA) expects to enter edibles market in Q1
The Health Canada licensed 51,000 sq. foot manufacturing facility is located in Winnipeg, Manitoba. Source: Agraflora
  • AgraFlora Organics has completed the first phase of R&D trials at its automated edibles manufacturing facility
  • The Health Canada licensed 51,000 sq. foot manufacturing facility is located in Winnipeg, Manitoba
  • The company has created efficient processes for desired formulations and product varieties and expects to enter the edibles market in Q1 of 2021
  • The company said its edibles facility will utilize its current state of the art laboratory set-up to produce approximately 60,000 pieces per eight-hour shift
  • AgraFlora is up 40 per cent to C$0.035 per share

AgraFlora (AGRA) Organics has completed the first phase of R&D trials at its automated edibles manufacturing facility.

The Health Canada licensed 51,000 square-foot manufacturing facility is located in Winnipeg, Manitoba.

Prior to receiving a standard processing license from Health Canada, AgraFlora started cultivating long-term production relationships through Research and Development trials utilizing the company’s Health Canada R&D license.

The development phase of the R&D trials is now complete and the company has created efficient processes for desired formulations and product varieties and expects to enter the edibles market in the first quarter of 2021.

James Fletcher, Edibles and Infusions Corporation (AgraFlora's subsidiary) Co-Founder and Operational Manager, said supply contracts continue to move forward with the company's Licensed Producer relationships.

"We are confident that our gummies with consistent and flavourful variants will soon dominate the gummies category. Our family’s 97 years of confectionary experience provides us a solid culture of quality, craftmanship and efficiency to offer a variety of infused gummy products to multiple LP clients at a time,” he said.

Edibles and Infusions Corporation is a joint venture formed between AgraFlora and one of North America’s leading confectionary manufacturing families.

The company said its edibles facility will utilize its current state of the art laboratory set-up to produce approximately 60,000 pieces per eight-hour shift and can manage a variety of brands at once given the efficient nature of the automated production line.

The facility’s equipment and design allow Edibles and Infusions Corporation to easily pivot and provide specific dosing and custom gummies that meet regulatory requirements and customer specifications. These efficiencies also allow AgraFlora to produce saleable products at a lower cost.

AgraFlora is up 40 per cent to C$0.035 per share at 1:14pm EST.


Subscribe


More From The Market Herald
Canbud (CSE:CBDX) launches plant-based protein brand

" Canbud (CSE:CBDX) launches plant-based protein brand

Canbud Distribution Corp. (CBDX) has launched a plant-based protein brand called Empathy Plant Co.™
Radient Technologies (TSXV:RTI) participates in medical cannabis study

" Nass Valley Gateway (CSE:NVG.CN) announces offering of 30 new products

Nass Valley Gateway (NVG.CN) is offering 30 new products, including an expanded pet menu.
Liposome structure cell 3D rendering - The Market Herald Canada

" Innocan Pharma (CSE:INNO) produces CBD loaded liposomes

Innocan Pharma Corp. (INNO) successfully produced CBD loaded liposomes under aseptic conditions.
Eguana Technologies (TSXV:EGT) releases 2020 annual results

" Aurora Cannabis (TSXV:ACB) announces US$125 million bought deal financing

Aurora Cannabis Inc. (ACB) pushes for a deal amounting to US$125 million through bought deal financing.